Amwise Diagnostics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$10M
- Investors
-
4
Amwise Diagnostics General Information
Description
Provider of precision medical service focused on cancer. The company's genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal adverse effects. The company's existing technology can identify patients who have high risk of recurrence or metastasis of breast cancer, allowing timely administration of necessary treatment.
Contact Information
Website
www.amwisediagnostics.comCorporate Office
- 3F., No.40, Sec. 2, Dunhua S. Rd.
- Da'an Dist.
- Taipei, 106-83
- Taiwan
Corporate Office
- 3F., No.40, Sec. 2, Dunhua S. Rd.
- Da'an Dist.
- Taipei, 106-83
- Taiwan
Amwise Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 25-Feb-2020 | $10M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 01-Jan-2016 | Completed | Startup |
Amwise Diagnostics Patents
Amwise Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022225447-A1 | Risk assessment method of breast cancer recurrence or metastasis and kit thereof | Inactive | 20-Apr-2021 | ||
| EP-3298167-A2 | Gene expression profiles and uses thereof in breast cancer | Active | 19-May-2015 | ||
| EP-3298167-A4 | Gene expression profiles and uses thereof in breast cancer | Active | 19-May-2015 | ||
| EP-3298167-B1 | Gene expression profiles and uses thereof in breast cancer | Inactive | 19-May-2015 | ||
| US-20180298449-A1 | Gene expression profiles and uses thereof in breast cancer | Inactive | 19-May-2015 | C12Q1/6886 |
Amwise Diagnostics Signals
Amwise Diagnostics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Simcere | VC-Backed Company | Minority | ||
| Alibaba Entrepreneurs Fund | Corporate Venture Capital | Minority | ||
| Lippo Karawaci | Real Estate | Minority | ||
| WI Harper Group | Venture Capital | Minority |
Amwise Diagnostics FAQs
-
When was Amwise Diagnostics founded?
Amwise Diagnostics was founded in 2015.
-
Where is Amwise Diagnostics headquartered?
Amwise Diagnostics is headquartered in Taipei, Taiwan.
-
What is the size of Amwise Diagnostics?
Amwise Diagnostics has 25 total employees.
-
What industry is Amwise Diagnostics in?
Amwise Diagnostics’s primary industry is Laboratory Services (Healthcare).
-
Is Amwise Diagnostics a private or public company?
Amwise Diagnostics is a Private company.
-
What is Amwise Diagnostics’s current revenue?
The current revenue for Amwise Diagnostics is .
-
How much funding has Amwise Diagnostics raised over time?
Amwise Diagnostics has raised $10M.
-
Who are Amwise Diagnostics’s investors?
Simcere, Alibaba Entrepreneurs Fund, Lippo Karawaci, and WI Harper Group have invested in Amwise Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process